Skip to content
PubMed This is a summary of 69 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 69 referenced papers

Top Authors

Li J
Chinese Academy of Medical Sciences & Peking Union Medical College
Satoshi Kuwabara
Chiba University
Daobin Zhou
Chinese Academy of Medical Sciences & Peking Union Medical College
Sonoko Misawa
Chiba University
Xinxin Cao
Chinese Academy of Medical Sciences & Peking Union Medical College
Michael P. Lunn
National Hospital for Neurology and Neurosurgery
Hao Zhao
Chinese Academy of Medical Sciences & Peking Union Medical College
Stephen Keddie
Royal London Hospital
Emiko Sakaida
Chiba University Hospital

Top Institutions

Ranked by publications Top 10 institutions
01

Chinese Academy of Medical Sciences & Peking Union Medical College

Beijing, China

24 papers
05

National Hospital for Neurology and Neurosurgery

London, United Kingdom

16 papers
06

Royal London Hospital

London, United Kingdom

10 papers
Contributors Stephen Keddie
07

University College London Hospitals NHS Foundation Trust

London, United Kingdom

12 papers
08

International University of Health and Welfare

Ōtawara, Japan

8 papers
Contributors Chiaki Nakaseko
09

Université de Limoges

Limoges, France

11 papers
10

Keio University

Tokyo, Japan

7 papers

References

References (69)
  1. 1

    CT characteristics in 24 patients with POEMS syndrome.

    Shi X, Hu S, Luo X, et al.

    Acta radiologica (Stockholm, Sweden : 1987) 2016; (57(1)):51-7 doi:10.1177/0284185114564614.

    PMID: 25571895
  2. 2

    Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome.

    Karam C, Klein CJ, Dispenzieri A, et al.

    Neurology 2015; (84(19)):1981-7 doi:10.1212/WNL.0000000000001565.

    PMID: 25878176
  3. 3

    Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome.

    Ye W, Wang C, Cai QQ, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016; (31(2)):275-83 doi:10.1093/ndt/gfv261.

    PMID: 26130736
  4. 4

    Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy.

    Naddaf E, Dispenzieri A, Mandrekar J, Mauermann ML

    Muscle & nerve 2015; (52(4)):658-9 doi:10.1002/mus.24768.

    PMID: 26179010
  5. 5

    POEMS syndrome: update on diagnosis, risk-stratification, and management.

    Dispenzieri A

    American journal of hematology 2015; (90(10)):951-62 doi:10.1002/ajh.24171.

    PMID: 26331353
  6. 6

    Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.

    Misawa S, Sato Y, Katayama K, et al.

    BMJ open 2015; (5(11)):e009157 doi:10.1136/bmjopen-2015-009157.

    PMID: 26560063
  7. 7

    Bone lesions in Chinese POEMS syndrome patients: imaging characteristics and clinical implications.

    Wang F, Huang X, Zhang Y, et al.

    PeerJ 2016; (4()):e2294 doi:10.7717/peerj.2294.

    PMID: 27547585
  8. 8

    Clinical spectrum of Castleman disease-associated neuropathy.

    Naddaf E, Dispenzieri A, Mandrekar J, Mauermann ML

    Neurology 2016; (87(23)):2457-2462 doi:10.1212/WNL.0000000000003405.

    PMID: 27807187
  9. 9

    POEMS Syndrome: an Enigma.

    Warsame R, Yanamandra U, Kapoor P

    Current hematologic malignancy reports 2017; (12(2)):85-95 doi:10.1007/s11899-017-0367-0.

    PMID: 28299525
  10. 10

    Osteolytic-variant POEMS syndrome: an uncommon presentation of "osteosclerotic" myeloma.

    Clark MS, Howe BM, Glazebrook KN, et al.

    Skeletal radiology 2017; (46(6)):817-823 doi:10.1007/s00256-017-2607-8.

    PMID: 28343327
  11. 11

    POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management.

    Dispenzieri A

    American journal of hematology 2017; (92(8)):814-829 doi:10.1002/ajh.24802.

    PMID: 28699668
  12. 12

    Plexogenic pulmonary hypertension associated with POEMS syndrome.

    Czeczok T, Lin P, Yi E

    Respiratory medicine case reports 2017; (22()):168-170 doi:10.1016/j.rmcr.2017.08.011.

    PMID: 28856089
  13. 13

    POEMS Syndrome: Therapeutic Options.

    Jaccard A

    Hematology/oncology clinics of North America 2018; (32(1)):141-151 doi:10.1016/j.hoc.2017.09.011.

    PMID: 29157615
  14. 14

    [Analysis of clinical features of 23 patients with POEMS syndrome].

    Hu P, Luo YY, Wu J, Gao LL

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2017; (49(6)):985-989.

    PMID: 29263469
  15. 15

    Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan.

    Kawajiri-Manako C, Sakaida E, Ohwada C, et al.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018; (24(6)):1180-1186 doi:10.1016/j.bbmt.2018.01.026.

    PMID: 29409882
  16. 16

    A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.

    Li J, Huang XF, Cai QQ, et al.

    American journal of hematology 2018; (93(6)):803-809 doi:10.1002/ajh.25100.

    PMID: 29603764
  17. 17

    Clonal immunoglobulin λ light-chain gene rearrangements detected by next generation sequencing in POEMS syndrome.

    Kawajiri-Manako C, Mimura N, Fukuyo M, et al.

    American journal of hematology 2018; (93(9)):1161-1168 doi:10.1002/ajh.25213.

    PMID: 30015379
  18. 18

    POEMS syndrome.

    Keddie S, Lunn MP

    Current opinion in neurology 2018; (31(5)):551-558 doi:10.1097/WCO.0000000000000610.

    PMID: 30138145
  19. 19

    Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome.

    Pihan M, Keddie S, D'Sa S, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2018; (5(5)):e486 doi:10.1212/NXI.0000000000000486.

    PMID: 30175160
  20. 20

    Prevalence and Course of Endocrinopathy in POEMS Syndrome.

    Caimari F, Keddie S, Lunn MP, et al.

    The Journal of clinical endocrinology and metabolism 2019; (104(6)):2140-2146 doi:10.1210/jc.2018-01516.

    PMID: 30239770
  21. 21

    Proposal of new clinical diagnostic criteria for POEMS syndrome.

    Suichi T, Misawa S, Sato Y, et al.

    Journal of neurology, neurosurgery, and psychiatry 2019; (90(2)):133-137 doi:10.1136/jnnp-2018-318514.

    PMID: 30279213
  22. 22

    Improvement of thyroid function in POEMS syndrome after combination therapy of lenalidomide and dexamethasone.

    Yang H, Zhao H, Huang X, et al.

    Leukemia & lymphoma 2019; (60(2)):483-487 doi:10.1080/10428194.2018.1485909.

    PMID: 30407096
  23. 23

    POEMS syndrome: clinical update.

    Brown R, Ginsberg L

    Journal of neurology 2019; (266(1)):268-277 doi:10.1007/s00415-018-9110-6.

    PMID: 30498913
  24. 24

    Effectiveness of pulmonary vasodilators on pulmonary hypertension associated with POEMS syndrome.

    Ohashi K, Nishimura R, Sugimoto S, et al.

    Respirology case reports 2019; (7(4)):e00411 doi:10.1002/rcr2.411.

    PMID: 30847222
  25. 25

    Endocrine Manifestations in POEMS Syndrome: a case report and literature review.

    Li H, Huang Y, Li Y, et al.

    BMC endocrine disorders 2019; (19(1)):33 doi:10.1186/s12902-019-0355-6.

    PMID: 30902082
  26. 26

    POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.

    Dispenzieri A

    American journal of hematology 2019; (94(7)):812-827 doi:10.1002/ajh.25495.

    PMID: 31012139
  27. 27

    POEMS Syndrome: Bone Marrow, Laboratory, and Clinical Findings in 24 Korean Patients.

    Shim H, Seol CA, Park CJ, et al.

    Annals of laboratory medicine 2019; (39(6)):561-565 doi:10.3343/alm.2019.39.6.561.

    PMID: 31240884
  28. 28

    Clinical and electrophysiological profiles in early recognition of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome.

    Wang Q, Liu P, Ji LL, et al.

    Chinese medical journal 2019; (132(14)):1666-1672 doi:10.1097/CM9.0000000000000318.

    PMID: 31268911
  29. 29

    Prevalence, clinical profiles, and prognosis of POEMS syndrome in Japanese nationwide survey.

    Suichi T, Misawa S, Beppu M, et al.

    Neurology 2019; (93(10)):e975-e983 doi:10.1212/WNL.0000000000008062.

    PMID: 31371568
  30. 30

    POEMS syndrome: a rare cause of adrenal insufficiency in a young male.

    Prokop J, Estorninho J, Marote S, et al.

    Endocrinology, diabetes & metabolism case reports 2019; (2019()).

    PMID: 31967972
  31. 31

    High rates of venous and arterial thrombotic events in patients with POEMS syndrome: results from the UCLH (UK) POEMS Registry.

    Sayar Z, Weatherill A, Keddie S, et al.

    Blood advances 2020; (4(10)):2139-2142 doi:10.1182/bloodadvances.2020001492.

    PMID: 32421810
  32. 32

    Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.

    Keddie S, Foldes D, Caimari F, et al.

    Neurology 2020; (95(3)):e268-e279 doi:10.1212/WNL.0000000000009940.

    PMID: 32606227
  33. 33

    Atypical polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes syndrome without polyneuropathy: A case report.

    Li Q, Xu F, Duan JF, Tang YF

    Medicine 2020; (99(27)):e20812 doi:10.1097/MD.0000000000020812.

    PMID: 32629667
  34. 34

    Ischemic stroke in patients with POEMS syndrome.

    Feng J, Gao XM, Zhao H, et al.

    Blood advances 2020; (4(14)):3427-3434 doi:10.1182/bloodadvances.2020001865.

    PMID: 32722780
  35. 35

    Ischemic Stroke in a Patient With Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes Syndrome Treated With Lenalidomide.

    Sodavarapu S, Mahajan A

    Cureus 2020; (12(7)):e9346 doi:10.7759/cureus.9346.

    PMID: 32850219
  36. 36

    POEMS syndrome: A multisystem clonal disorder.

    Ali T, Qazilbash MH

    European journal of haematology 2021; (106(1)):14-18 doi:10.1111/ejh.13514.

    PMID: 32889731
  37. 37

    Endocrine Evaluation in POEMS Syndrome: A Cohort Study.

    Yang H, Zhao H, Gao X, et al.

    Frontiers in endocrinology 2020; (11()):536241 doi:10.3389/fendo.2020.536241.

    PMID: 33193075
  38. 38

    Peripheral retinal leakage in POEMS syndrome.

    Carey AR, Jeyaseelan P

    International journal of retina and vitreous 2021; (7(1)):6 doi:10.1186/s40942-020-00278-1.

    PMID: 33436019
  39. 39

    [POEMS syndrome: Diagnosis, stratification, treatments].

    Talbot A, Jaccard A, Arnulf B

    La Revue de medecine interne 2021; (42(5)):320-329 doi:10.1016/j.revmed.2021.02.007.

    PMID: 33678446
  40. 40

    Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.

    Khouri J, Nakashima M, Wong S

    JAMA oncology 2021; (7(9)):1383-1391 doi:10.1001/jamaoncol.2021.0586.

    PMID: 34081097
  41. 41

    Cerebral large artery stenosis and occlusion in POEMS syndrome.

    Sugiyama A, Yokota H, Misawa S, et al.

    BMC neurology 2021; (21(1)):239 doi:10.1186/s12883-021-02260-2.

    PMID: 34167480
  42. 42

    Pericardial Tamponade and Other Cardiac Complications in POEMS Syndrome.

    Levene J, Murray N, Desai S, et al.

    JACC. Case reports 2021; (3(2)):286-290 doi:10.1016/j.jaccas.2020.12.027.

    PMID: 34317520
  43. 43

    Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome.

    Gao XM, Yu YY, Zhao H, et al.

    Annals of hematology 2021; (100(11)):2755-2761 doi:10.1007/s00277-021-04609-6.

    PMID: 34331562
  44. 44

    A retrospective analysis of endocrinopathy manifestations in 136 Chinese patients with POEMS syndrome.

    Shao Y, Zhang C, Wang X, et al.

    Neuro endocrinology letters 2021; (42(5)):292-296.

    PMID: 34506092
  45. 45

    POEMS syndrome causing left ventricular hypertrophy, myocardial dysfunction, and pericardial effusion: a case report.

    Wang S, Wu X, Li H

    European heart journal. Case reports 2022; (6(1)):ytab504 doi:10.1093/ehjcr/ytab504.

    PMID: 35174305
  46. 46

    Unraveling unique features of plasma cell clones in POEMS syndrome with single-cell analysis.

    Isshiki Y, Oshima M, Mimura N, et al.

    JCI insight 2022; (7(20)).

    PMID: 36129760
  47. 47

    Comprehensive Diagnosis and Management of POEMS Syndrome.

    D'Sa S, Khwaja J, Keddie S, et al.

    HemaSphere 2022; (6(11)):e796 doi:10.1097/HS9.0000000000000796.

    PMID: 36340912
  48. 48

    Polyneuropathy organomegaly endocrinopathy M-protein and skin changes syndrome with ascites as an early-stage manifestation: A case report.

    Zhou XL, Chang YH, Li L, et al.

    World journal of clinical cases 2023; (11(1)):135-142 doi:10.12998/wjcc.v11.i1.135.

    PMID: 36687199
  49. 49

    Regular assessment of serum vascular endothelial growth factor levels to monitor POEMS syndrome.

    Gentile F, Terenghi F, Doneddu PE, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2024; (45(2)):727-733 doi:10.1007/s10072-023-07064-5.

    PMID: 37702830
  50. 50

    Long-Term Outcomes of Autologous Stem Cell Transplantation in Patients with Newly Diagnosed POEMS Syndrome.

    Li AA, Gao XM, Zhao H, et al.

    Transplantation and cellular therapy 2024; (30(2)):207.e1-207.e7 doi:10.1016/j.jtct.2023.11.001.

    PMID: 37931801
  51. 51

    Pulmonary manifestations of POEM syndrome: a retrospective analysis of 282 cases.

    Huang Y, Luo Y, Hou H, Gao J

    BMC pulmonary medicine 2023; (23(1)):465 doi:10.1186/s12890-023-02741-9.

    PMID: 37993859
  52. 52

    A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea.

    Kook HW, Jang JE, Min CK, et al.

    Journal of Korean medical science 2024; (39(2)):e5 doi:10.3346/jkms.2024.39.e5.

    PMID: 38225781
  53. 53

    Efficacy of bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed POEMS syndrome patients.

    Fang F, Lan XX, Hu RH, et al.

    Therapeutic advances in neurological disorders 2024; (17()):17562864231219151 doi:10.1177/17562864231219151.

    PMID: 38288324
  54. 54

    Detection of clonal plasma cells in POEMS syndrome using multiparameter flow cytometry.

    Ishii A, Tsukamoto S, Mimura N, et al.

    Scientific reports 2024; (14(1)):10362 doi:10.1038/s41598-024-61034-1.

    PMID: 38710832
  55. 55

    Requirement of Repeated Serum VEGF Measurements in POEMS Syndrome.

    Nomura T, Iwata I, Eguchi K, et al.

    Internal medicine (Tokyo, Japan) 2025; (64(5)):769-773 doi:10.2169/internalmedicine.4086-24.

    PMID: 39085069
  56. 56

    Case report: DKRd regimen in the treatment of newly diagnosed POEMS syndrome and literature review.

    Wang J, Liao W, Liu Z, Kong D

    Frontiers in oncology 2024; (14()):1417380 doi:10.3389/fonc.2024.1417380.

    PMID: 39148901
  57. 57

    Dramatically elevated plasma vascular endothelial growth factor levels from influenza A infection in polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome: A case report.

    Kannan A, Zhuo Y, Banerjee R

    EJHaem 2024; (5(4)):842-844 doi:10.1002/jha2.965.

    PMID: 39157604
  58. 58

    POEMS Syndrome.

    Jaccard A, Pascal V, Magy L, Roussel M

    Presse medicale (Paris, France : 1983) 2025; (54(1)):104270 doi:10.1016/j.lpm.2025.104270.

    PMID: 39848571
  59. 59

    Growth Differentiation Factor-15 as a Potential Biomarker for Renal Involvement in POEMS Syndrome.

    Huang Y, Chen J, Yao Y, et al.

    International journal of nephrology and renovascular disease 2025; (18()):133-142 doi:10.2147/IJNRD.S507148.

    PMID: 40416392
  60. 60

    POEMS syndrome presenting with Vibrio vulnificus-like cutaneous lesions: a CARE guidelines-compliant case report.

    Li X, Lin B, Lin L, Song C

    Frontiers in medicine 2025; (12()):1625877 doi:10.3389/fmed.2025.1625877.

    PMID: 40697923
  61. 61

    Monoclonal-related neuropathies: diagnosis, prognosis, and outcomes.

    Jaccard A, Magy L, Arnulf B, et al.

    Hematology. American Society of Hematology. Education Program 2025; (2025(1)):385-392 doi:10.1182/hematology.2025000728.

    PMID: 41348001
  62. 62

    Refractory ascites: unveiling POEMS syndrome as the underlying cause: a case report and literature review.

    Liu S, He Y, Qin J, et al.

    Frontiers in medicine 2025; (12()):1704902 doi:10.3389/fmed.2025.1704902.

    PMID: 41404586
  63. 63

    Neurological Peculiarities of POEMS Syndrome: Experience From a Brazilian University Center.

    Rosenstein RF, Soares Baima JP, Meneguin Pereira TD, et al.

    Muscle & nerve 2026; (73(3)):421-426 doi:10.1002/mus.70114.

    PMID: 41408967
  64. 64

    POEMS syndrome: a neuromuscular perspective.

    Gonçalves TAP, Donadel CD, Frezatti RSS, et al.

    Journal of neurology, neurosurgery, and psychiatry 2026; (97(4)):293-301 doi:10.1136/jnnp-2025-336633.

    PMID: 41617534
  65. 65

    Atypical Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes (POEMS) Syndrome.

    Bishara M, Homeniuk A, Patel A, et al.

    Cureus 2026; (18(2)):e103791 doi:10.7759/cureus.103791.

    PMID: 41869173
  66. 66

    When Foot Drop Tells a Bigger Story: POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Plasma Cell Disorder, and Skin Changes) Syndrome Revealed by Femoral Plasmacytoma.

    Al-Anbagi U, Ahmed S, Telfah H, et al.

    Cureus 2026; (18(2)):e103751 doi:10.7759/cureus.103751.

    PMID: 41869182
  67. 67

    Thrombosis in Neuromuscular Medicine: Current Evidence, Unmet Needs, and Future Directions.

    Quak ZX, Wang F, Tay SKH, et al.

    Journal of clinical medicine 2026; (15(8)) doi:10.3390/jcm15082810.

    PMID: 42074613
  68. 68

    [Recent advances in pathogenesis, diagnosis, and therapeutic strategies for POEMS syndrome].

    Tsukamoto S

    [Rinsho ketsueki] The Japanese journal of clinical hematology 2026; (67(5)):453-461 doi:10.11406/rinketsu.67.453.

    PMID: 42236249
  69. 69

    Polyneuropathy, Organomegaly, Endocrinopathy, M-Protein, and Skin Changes (POEMS) Syndrome With Characteristic Muscle Biopsy Findings and Without M-Protein.

    Yalovitser J, Seyam M, DeWitt J, et al.

    The neurologist 2026; doi:10.1097/NRL.0000000000000688.

    PMID: 42611186